Skip to content

Management of Obese patients suffering from Type-2 Diabetes Mellitus with Ayurvedic medication.

Comparative study of Nisha-amalaki and Metformin in obese patients of Type-2 Diabetes Mellitus (Madhumeha)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037263
Enrollment
60
Registered
2021-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Aman Chhabra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 30 to 60 years of either sex. Patients having Fasting Blood Sugar Level >126 mg/dLand/or Post Prandial Blood Sugar Level >200mg/dL. B.M.I. in between 25-30 kg/m2

Exclusion criteria

Exclusion criteria: Fasting Blood Sugar Level more than or equal to 200 mg/dL Post Prandial Blood Sugar Level more than or equal to 300mg/dL. Pregnant and lactating women. Patients with acute complications like cirrhosis of liver, Pancreatitis, and Hypoglycemic Shock. Patients with chronic complications like Nephropathy, Retinopathy and Neuropathy.

Design outcomes

Primary

MeasureTime frame
Lowering of Fasting Blood Glucose level and Post Prandial Blood Glucose levelsTimepoint: 60 days

Secondary

MeasureTime frame
Lowering of B.M.I. of patientsTimepoint: 60 days

Countries

India

Contacts

Public ContactAman Chhabra

Datta Meghe Institute of Medical Science Deemed to be University Wardha

vkuchewar@gmail.com9420998747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026